Home
China
World
Europe
Politics
Business
Opinions
Tech & Sci
Culture
Sports
Travel
Nature
Picture
Video
Live
TV
Specials
Learn Chinese
2025.04.15 22:25 GMT+8
The European Commission has approved for the first time an Alzheimer's therapy, the antibody Lecanemab, which targets the underlying disease processes
Updated
2025.04.15 22:25 GMT+8
CGTN
Copyright ©
SHARE
RELATED STORIES
{{#contents.0.videos}}
{{/contents.0.videos}}
{{#contents.0.pictures}}
{{/contents.0.pictures}} {{^contents.0.pictures}}
{{/contents.0.pictures}}
{{contents.0.title}}